Gamida Cell is a cell therapy pioneer working to turn cells into powerful therapeutics. Our proprietary nicotinamide (NAM) technology expands the number of cells while maintaining their intrinsic properties to create potentially curative cell therapy products and candidates for patients with cancer. Our stem cell transplant therapy was approved by the US FDA in April 2023. Clinical study of our NK cell therapy candidate GDA-201 is ongoing.
View Top Employees from Gamida Cell Ltd.Website | http://www.gamida-cell.com |
Ticker | GMDA |
Revenue | $8 million |
Funding | $75 million |
Employees | 120 (114 on RocketReach) |
Founded | 1998 |
Address | 673 Boylston St 4th Floor, Boston, Massachusetts 02116, US |
Phone | (617) 892-9080 |
Fax | +972 2-659-5616 |
Technologies |
JavaScript,
HTML,
Google Analytics
+27 more
(view full list)
|
Industry | Biotechnology, Biotechnology Research, Drug Manufacturing & Research, Pharmaceuticals, Science and Engineering, Drug Discovery, Healthcare, Medical Device, Health Care, Therapeutics |
Web Rank | 6 Million |
Keywords | Cell Therapies, Cancer Treatment, Stem Cell Research |
Competitors | Athersys, Brainstorm Cell Therapeutics, Capricor Therapeutics, Inc., ReNeuron Group Plc, StemCyte Cord Blood Bank |
SIC | SIC Code 87 Companies, SIC Code 873 Companies |
NAICS | NAICS Code 3254 Companies, NAICS Code 32 Companies, NAICS Code 32541 Companies, NAICS Code 541 Companies, NAICS Code 325 Companies, NAICS Code 54 Companies |
Looking for a particular Gamida Cell Ltd. employee's phone or email?
The Gamida Cell Ltd. annual revenue was $8 million in 2024.
Abigail Jenkins is the President and Chief Executive Officer of Gamida Cell Ltd..
114 people are employed at Gamida Cell Ltd..
Gamida Cell Ltd. is based in Boston, Massachusetts.
The NAICS codes for Gamida Cell Ltd. are [3254, 32, 32541, 541, 325, 54].
The SIC codes for Gamida Cell Ltd. are [87, 873].